Elizabeth Bruckheimer
Chief Tech/Sci/R&D Officer at PANBELA THERAPEUTICS, INC.
Profile
Elizabeth Bruckheimer is currently the Chief Scientific Officer & Vice President at Panbela Therapeutics, Inc. She previously worked as the Director-Preclinical Development at Champions Oncology, Inc. and as the VP-Drug Development & Regulatory Affairs at Cancer Prevention Pharmaceuticals, Inc. She also worked as an Associate Director & Manager at Systems Medicine, Inc. Dr. Bruckheimer holds a doctorate degree from The University of Texas at Austin and an undergraduate degree from the University of Arizona.
Elizabeth Bruckheimer active positions
| Companies | Position | Start |
|---|---|---|
| PANBELA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-05-31 |
Former positions of Elizabeth Bruckheimer
| Companies | Position | End |
|---|---|---|
| CANCER PREVENTION PHARMACEUTICALS INC | Corporate Officer/Principal | 2021-12-31 |
Systems Medicine, Inc.
 Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Corporate Officer/Principal | - |
| CHAMPIONS ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Elizabeth Bruckheimer
| The University of Texas at Austin | Doctorate Degree |
| University of Arizona | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CHAMPIONS ONCOLOGY, INC. | Health Technology |
| PANBELA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Cancer Prevention Pharmaceuticals, Inc.
 Cancer Prevention Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cancer Prevention Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases and gastrointestinal conditions. The company’s pipeline consists of Gastrointestinal and Orphan. Cancer Prevention Pharmaceuticals was founded by Dr. Frank Meyskens and Gene Gerner in June 9, 2008 and is headquartered in Tucson, AZ. | Health Technology |
Systems Medicine, Inc.
Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Health Technology |
- Stock Market
- Insiders
- Elizabeth Bruckheimer
